Insider trading disclosure of December, 16 2016
Interview for Redmedia with the Executive Director of Sopharma AD Ognian Donev – about the challenges in the pharmaceutical industry, the successful past year and the plans for 2017
Ognian Donev is Chairman of the Board of Directors and Executive Director of the pharmaceutical company Sopharma. He is also Chairman of the International Chamber of Commerce for Bulgaria, as well as Chairman of the Board of Trustees of the Medical University, Sofia.
Insider trading disclosure of December, 14 2016 received by DIH AD
Insider trading disclosure of December, 13 2016 received by DIH AD
Insider trading disclosure of December, 12 2016 received by DIH AD
Insider trading disclosure of December, 15 2016
Insider trading disclosure of December, 15 2016 received by Ognian Donev
Insider trading disclosure of December, 15 2016 received by Elpharma AD
Notification for tender offer
Sopharma AD (the “Company”) hereby notifies that on 14 December 2016 Sopharma AD filed with the Financial Supervision Commission a tender offering for the shares of all other shareholders in Unipharm AD.
Sopharma AD as a offeree states that it does not own 1 342 234 shares, representing 22.37% from the total number of sahres with ISIN BG1100154076 and from the votes in the general meeting of Unipharm AD and files the tender offering to the remaining sahreholders owning ordinary shares of Unipharma AD for the purchase of those shares.